{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:46:06Z","timestamp":1761061566878,"version":"3.37.3"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fundamental Research Grant Scheme Fasa 1\/2017","award":["Grant no. 203\/CIPPM\/6711599"],"award-info":[{"award-number":["Grant no. 203\/CIPPM\/6711599"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s11033-021-07006-4","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:03:41Z","timestamp":1641254621000},"page":"1529-1535","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Functional roles of cytokines in infectious disease associated colorectal carcinogenesis"],"prefix":"10.1007","volume":"49","author":[{"given":"Ching Yi","family":"Ong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3643-2908","authenticated-orcid":false,"given":"Eshtiyag Abdalla","family":"Abdalkareem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1915-6606","authenticated-orcid":false,"given":"Boon Yin","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,4]]},"reference":[{"issue":"2","key":"7006_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3892\/etm.2020.9535","volume":"21","author":"P Ge","year":"2021","unstructured":"Ge P, Ong CY, Abdalkareem AE, Khoo BY, Yuan B (2021) IFN\u03b3 and IL18 in conditioned media of parasite infected host and IL21 silenced colorectal cancer cells. Exp Ther Med 21(2):103","journal-title":"Exp Ther Med"},{"issue":"11","key":"7006_CR2","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/1469-0691.12308","volume":"19","author":"A Huppert","year":"2013","unstructured":"Huppert A, Katriel G (2013) Mathematical modelling and prediction in infectious disease epidemiology. Clin Microbiol Infect 19(11):999\u20131005. https:\/\/doi.org\/10.1111\/1469-0691.12308","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"7006_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1179\/136485905X19883","volume":"99","author":"D-C Qiu","year":"2005","unstructured":"Qiu D-C, Hubbard AE, Zhong B, Zhang Y, Spear RC (2005) A matched, case-control study of the association between Schistosoma japonicum and liver and colon cancers, in rural China. Ann Trop Med Parasitol 99(1):47\u201352. https:\/\/doi.org\/10.1179\/136485905X19883","journal-title":"Ann Trop Med Parasitol"},{"key":"7006_CR4","first-page":"1","volume-title":"Monograph on the evaluation of carcinogenic risks to humans. Part B: biological agents","author":"IARC","year":"2011","unstructured":"IARC (2011) Monograph on the evaluation of carcinogenic risks to humans. Part B: biological agents, vol 100. World Health Organization, International Agency for Research on Cancer, Lyon, pp 1\u2013487"},{"issue":"1","key":"7006_CR5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/imr.12616","volume":"281","author":"G Kaplanski","year":"2018","unstructured":"Kaplanski G (2018) Interleukin-18: biological properties and role in disease pathogenesis. Immunol Rev 281(1):138\u2013153","journal-title":"Immunol Rev"},{"issue":"6","key":"7006_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1023\/a:1020600230977","volume":"22","author":"O Ludwiczek","year":"2002","unstructured":"Ludwiczek O, Kaser A, Novick D, Dinarello CA, Rubinstein M, Vogel W, Tilg H (2002) Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease. J Clin Immunol 22(6):331\u2013337. https:\/\/doi.org\/10.1023\/a:1020600230977","journal-title":"J Clin Immunol"},{"issue":"11","key":"7006_CR7","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1093\/carcin\/bgr189","volume":"32","author":"ML Slattery","year":"2011","unstructured":"Slattery ML, Lundgreen A, Bondurant KL, Wolff RK (2011) Interferon-signaling pathway associations with colon and rectal cancer risk and subsequent survival. Carcinogenesis 32(11):1660\u20131667. https:\/\/doi.org\/10.1093\/carcin\/bgr189","journal-title":"Carcinogenesis"},{"issue":"11","key":"7006_CR8","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1128\/IAI.00749-16","volume":"84","author":"EK Naglak","year":"2016","unstructured":"Naglak EK, Morrison SG, Morrison RP (2016) Gamma interferon is required for optimal antibody-mediated immunity against genital chlamydia infection. Infect Immun 84(11):3232\u20133242. https:\/\/doi.org\/10.1128\/IAI.00749-16","journal-title":"Infect Immun"},{"issue":"8227","key":"7006_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(81)91734-7","volume":"317","author":"MC Chen","year":"1981","unstructured":"Chen MC, Chuang CY, Wang FP, Chang PY, Chen YJ, Tang YC, Chou SC (1981) Colorectal cancer and schistosomiasis. Lancet 317(8227):971\u2013973. https:\/\/doi.org\/10.1016\/S0140-6736(81)91734-7","journal-title":"Lancet"},{"key":"7006_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1477-7819-8-68","volume":"8","author":"OEH Salim","year":"2010","unstructured":"Salim OEH, Hamid HK, Mekki SO, Suleiman SH, Ibrahim SZ (2010) Colorectal carcinoma associated with schistosomiasis: a possible causal relationship. World J Surg Oncol 8:68. https:\/\/doi.org\/10.1186\/1477-7819-8-68","journal-title":"World J Surg Oncol"},{"issue":"7 Suppl","key":"7006_CR11","first-page":"1929s","volume":"54","author":"MP Rosin","year":"1994","unstructured":"Rosin MP, Anwar WA, Ward AJ (1994) Inflammation, chromosomal instability, and cancer: the schistosomiasis model. Cancer Res 54(7 Suppl):1929s\u20131933s","journal-title":"Cancer Res"},{"issue":"2","key":"7006_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00384-006-0144-3","volume":"22","author":"KM Madbouly","year":"2007","unstructured":"Madbouly KM, Senagore AJ, Mukerjee A, Hussein AM, Shehata MA, Navine P, Delaney CP, Fazio VW (2007) Colorectal cancer in a population with endemic Schistosoma mansoni: is this an at-risk population? Int J Colorectal Dis 22(2):175\u2013181. https:\/\/doi.org\/10.1007\/s00384-006-0144-3","journal-title":"Int J Colorectal Dis"},{"issue":"3","key":"7006_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.chom.2014.02.003","volume":"15","author":"RS Goldszmid","year":"2014","unstructured":"Goldszmid RS, Dzutsev A, Trinchieri G (2014) Host immune response to infection and cancer: unexpected commonalities. Cell Host Microbe 15(3):295\u2013305. https:\/\/doi.org\/10.1016\/j.chom.2014.02.003","journal-title":"Cell Host Microbe"},{"key":"7006_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ebiom.2016.11.034","volume":"15","author":"H van Tong","year":"2017","unstructured":"van Tong H, Brindley PJ, Meyer CG, Velavan TP (2017) Parasite infection, carcinogenesis and human malignancy. EBioMedicine 15:12\u201323. https:\/\/doi.org\/10.1016\/j.ebiom.2016.11.034","journal-title":"EBioMedicine"},{"issue":"5","key":"7006_CR15","first-page":"211","volume":"12","author":"L-N Wang","year":"2015","unstructured":"Wang L-N, Cui Y-X, Ruge F, Jiang WG (2015) Interleukin 21 and its receptor play a role in proliferation, migration and invasion of breast cancer cells. Cancer Genomics Proteomics 12(5):211\u2013221","journal-title":"Cancer Genomics Proteomics"},{"issue":"6","key":"7006_CR16","doi-asserted-by":"publisher","first-page":"e24522","DOI":"10.4161\/onci.24522","volume":"2","author":"SJ Santegoets","year":"2013","unstructured":"Santegoets SJ, Turksma AW, Powell DJ Jr, Hooijberg E, de Gruijl TD (2013) IL-21 in cancer immunotherapy: at the right place at the right time. Oncoimmunology 2(6):e24522. https:\/\/doi.org\/10.4161\/onci.24522","journal-title":"Oncoimmunology"},{"issue":"5","key":"7006_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrd4296","volume":"13","author":"R Spolski","year":"2014","unstructured":"Spolski R, Leonard WJ (2014) Interleukin-21: a double-edged sword with therapeutic potential. Nat Rev Drug Discov 13(5):379\u2013395. https:\/\/doi.org\/10.1038\/nrd4296","journal-title":"Nat Rev Drug Discov"},{"issue":"2 Suppl","key":"7006_CR18","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","volume":"125","author":"DD Chaplin","year":"2010","unstructured":"Chaplin DD (2010) Overview of the immune response. J Allergy Clin Immunol 125(2 Suppl):S3-23. https:\/\/doi.org\/10.1016\/j.jaci.2009.12.980","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"7006_CR19","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s10616-018-0228-2","volume":"70","author":"EA Abdalkareem","year":"2018","unstructured":"Abdalkareem EA, Ong CY, Lim BH, Khoo BY (2018) Neutralizing FGF4 protein in conditioned medium of IL-21-silenced HCT116 cells restores the migratory activity of the colorectal cancer cells. Cytotechnology 70(5):1363\u20131374. https:\/\/doi.org\/10.1007\/s10616-018-0228-2","journal-title":"Cytotechnology"},{"issue":"Suppl","key":"7006_CR20","doi-asserted-by":"publisher","first-page":"S720","DOI":"10.1016\/S2222-1808(14)60714-3","volume":"4","author":"EA Abdalkareem","year":"2014","unstructured":"Abdalkareem EA, Tan GC, Abdalla HS, Lim BH, Khoo BY (2014) Identification of specific proteins in colorectal cancer patients with Schistosoma mansoni infection as a possible biomarker for the treatment of this infection. Asian Pac J Trop Dis 4(Suppl):S720\u2013S724","journal-title":"Asian Pac J Trop Dis"},{"issue":"11","key":"7006_CR21","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1084\/jem.20111106","volume":"208","author":"C Stolfi","year":"2011","unstructured":"Stolfi C, Rizzo A, Franz\u00e8 E, Rotondi A, Fantini MC, Sarra M, Caruso R, Monteleone I, Sileri P, Franceschilli L, Caprioli F, Ferrero S, MacDonald TT, Pallone F, Monteleone G (2011) Involvement of interleukin-21 in the regulation of colitis-associated colon cancer. J Exp Med 208(11):2279\u20132290","journal-title":"J Exp Med"},{"issue":"7","key":"7006_CR22","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1172\/JCI27727","volume":"116","author":"J Pesce","year":"2006","unstructured":"Pesce J, Kaviratne M, Ramalingam TR, Thompson RW, Urban JF, Cheever AW, Young DA, Collins M, Grusby MJ, Wynn TA (2006) The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Investig 116(7):2044\u20132055. https:\/\/doi.org\/10.1172\/JCI27727","journal-title":"J Clin Investig"},{"issue":"4","key":"7006_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.4161\/onci.19407","volume":"1","author":"R Kesselring","year":"2012","unstructured":"Kesselring R, Jauch D, Fichtner-Feigl S (2012) Interleukin 21 impairs tumour immunosurveillance of colitis-associated colorectal cancer. Oncoimmunology 1(4):537\u2013538. https:\/\/doi.org\/10.4161\/onci.19407","journal-title":"Oncoimmunology"},{"issue":"5","key":"7006_CR24","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1182\/blood-2006-05-021600","volume":"109","author":"BJ Marsland","year":"2007","unstructured":"Fr\u00f6hlich A, Marsland BJ, Sonderegger I, Kurrer M, Hodge MR, Harris NL, Kopf M (2007) IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo. Blood 109(5):2023\u20132031. https:\/\/doi.org\/10.1182\/blood-2006-05-021600","journal-title":"Blood"},{"key":"7006_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cyto.2018.04.007","volume":"108","author":"A Ariyaratne","year":"2018","unstructured":"Ariyaratne A, Szabo EK, Bowron J, Finney CAM (2018) Increases in helminth-induced IL-21 protein levels disappear upon sample freezing. Cytokine 108:179\u2013181. https:\/\/doi.org\/10.1016\/j.cyto.2018.04.007","journal-title":"Cytokine"},{"issue":"12","key":"7006_CR26","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nri2199","volume":"7","author":"RM Anthony","year":"2007","unstructured":"Anthony RM, Rutitzky LI, Urban JF Jr, Stadecker MJ, Gause WC (2007) Protective immune mechanisms in helminth infection. Nat Rev Immunol 7(12):975\u2013987. https:\/\/doi.org\/10.1038\/nri2199","journal-title":"Nat Rev Immunol"},{"issue":"5598","key":"7006_CR27","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1126\/science.1077002","volume":"298","author":"K Ozaki","year":"2002","unstructured":"Ozaki K, Spolski R, Feng CG, Qi C, Cheng J, Sher A, Morse HC III, Liu C, Schwartzberg PL, Leonard WJ (2002) A critical role for IL-21 in regulating immunoglobulin production. Science 298(5598):1630\u20131634. https:\/\/doi.org\/10.1126\/science.1077002","journal-title":"Science"},{"issue":"4","key":"7006_CR28","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/s1074-7613(02)00295-9","volume":"16","author":"MT Kasaian","year":"2002","unstructured":"Kasaian MT, Whitters MJ, Carter LL, Lowe LD, Jussif JM, Deng B, Johnson KA, Witek JS, Senices M, Konz RF, Wurster AL, Donaldson DD, Collins M, Young DA, Grusby MJ (2002) IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16(4):559\u2013569. https:\/\/doi.org\/10.1016\/s1074-7613(02)00295-9","journal-title":"Immunity"},{"issue":"4","key":"7006_CR29","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.4049\/jimmunol.172.4.2048","volume":"172","author":"J Brady","year":"2004","unstructured":"Brady J, Hayakawa Y, Smyth MJ, Nutt SL (2004) IL-21 induces the functional maturation of murine NK cells. J Immunol 172(4):2048\u20132058. https:\/\/doi.org\/10.4049\/jimmunol.172.4.2048","journal-title":"J Immunol"},{"issue":"1","key":"7006_CR30","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4049\/jimmunol.177.1.120","volume":"177","author":"JM Roda","year":"2006","unstructured":"Roda JM, Parihar R, Lehman A, Mani A, Tridandapani S, Carson WE (2006) Interleukin-21 enhances NK cell activation in response to antibody-coated targets. J Immunol 177(1):120\u2013129. https:\/\/doi.org\/10.4049\/jimmunol.177.1.120","journal-title":"J Immunol"},{"issue":"4","key":"7006_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1365-2567.2007.02730.x","volume":"123","author":"K Skak","year":"2008","unstructured":"Skak K, Frederiksen KS, Lundsgaard D (2008) Interleukin-21 activates human natural killer cells and modulates their surface receptor expression. Immunology 123(4):575\u2013583. https:\/\/doi.org\/10.1111\/j.1365-2567.2007.02730.x","journal-title":"Immunology"},{"issue":"2","key":"7006_CR32","doi-asserted-by":"publisher","first-page":"e1007614","DOI":"10.1371\/journal.ppat.1007614","volume":"15","author":"S Solaymani-Mohammadi","year":"2019","unstructured":"Solaymani-Mohammadi S, Berzofsky JA (2019) Interleukin 21 collaborates with interferon-\u03b3 for the optimal expression of interferon-stimulated genes and enhances protection against enteric microbial infection. PLoS Pathog 15(2): e1007614. https:\/\/doi.org\/10.1371\/journal.ppat.1007614","journal-title":"PLoS Pathog"},{"issue":"2","key":"7006_CR33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/mi.2007.17","volume":"1","author":"MC Fantini","year":"2008","unstructured":"Fantini MC, Monteleone G, MacDonald TT (2008) IL-21 comes of age as a regulator of effector T cells in the gut. Mucosal Immunol 1(2):110\u2013115. https:\/\/doi.org\/10.1038\/mi.2007.17","journal-title":"Mucosal Immunol"},{"issue":"2","key":"7006_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.canlet.2014.12.047","volume":"358","author":"MR Davis","year":"2015","unstructured":"Davis MR, Zhu Z, Hansen DM, Bai Q, Fang Y (2015) The role of IL-21 in immunity and cancer. Cancer Lett 358(2):107\u2013114. https:\/\/doi.org\/10.1016\/j.canlet.2014.12.047","journal-title":"Cancer Lett"},{"issue":"12","key":"7006_CR35","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1136\/gutjnl-2011-300953","volume":"60","author":"S Danese","year":"2011","unstructured":"Danese S, Malesci A, Vetrano S (2011) Colitis-associated cancer: the dark side of inflammatory bowel disease. Gut 60(12):1609\u20131610. https:\/\/doi.org\/10.1136\/gutjnl-2011-300953","journal-title":"Gut"},{"key":"7006_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-0998-4_15","volume-title":"Crohn\u2019s disease and ulcerative colitis","author":"Y Nemoto","year":"2012","unstructured":"Nemoto Y, Watanabe M (2012) The Th1, Th2, and Th17 paradigm in inflammatory bowel disease. In: Baumgart D (ed) Crohn\u2019s disease and ulcerative colitis. Springer, Boston, MA. https:\/\/doi.org\/10.1007\/978-1-4614-0998-4_15"},{"issue":"12","key":"7006_CR37","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1136\/gutjnl-2011-300612","volume":"60","author":"D Jauch","year":"2011","unstructured":"Jauch D, Martin M, Schiechl G, Kesselring R, Schlitt HJ, Geissler EK, Fichtner-Feigl S (2011) Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice. Gut 60(12):1678\u20131686. https:\/\/doi.org\/10.1136\/gutjnl-2011-300612","journal-title":"Gut"},{"key":"7006_CR38","doi-asserted-by":"publisher","first-page":"297645","DOI":"10.1155\/2009\/297645","volume":"2009","author":"I Monteleone","year":"2009","unstructured":"Monteleone I, Pallone F, Monteleone G (2009) Interleukin-23 and Th17 cells in the control of gut inflammation. Mediat Inflamm 2009:297645. https:\/\/doi.org\/10.1155\/2009\/297645","journal-title":"Mediat Inflamm"},{"issue":"3","key":"7006_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1046\/j.1365-2613.2001.iep0082-0201-x","volume":"82","author":"S Saeed","year":"2001","unstructured":"Saeed S, Revell PA (2001) Production and distribution of Interleukin 15 and its receptors (IL-15R\u03b1 and IL-R2\u03b2) in the implant interface tissues obtained during revision of failed total joint replacement. Int J Exp Pathol 82(3):201\u2013209. https:\/\/doi.org\/10.1046\/j.1365-2613.2001.iep0082-0201-x","journal-title":"Int J Exp Pathol"},{"issue":"5","key":"7006_CR40","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/s1074-7613(02)00429-6","volume":"17","author":"S Dubois","year":"2002","unstructured":"Dubois S, Mariner J, Waldmann TA, Tagaya Y (2002) IL-15R\u03b1 recycles and presents IL-15 in trans to neighbouring cells. Immunity 17(5):537\u2013547. https:\/\/doi.org\/10.1016\/s1074-7613(02)00429-6","journal-title":"Immunity"},{"issue":"5","key":"7006_CR41","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1172\/JCI119258","volume":"99","author":"WE Carson","year":"1997","unstructured":"Carson WE, Fehniger TA, Haldar S, Eckhert K, Lindemann MJ, Lai CF, Croce CM, Baumann H, Caligiuri MA (1997) A potential role for Interleukin-15 in the regulation of human natural killer cell survival. J Clin Investig 99(5):937\u2013943. https:\/\/doi.org\/10.1172\/JCI119258","journal-title":"J Clin Investig"},{"issue":"3","key":"7006_CR42","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1158\/2326-6066.CIR-15-0009","volume":"3","author":"TA Waldmann","year":"2015","unstructured":"Waldmann TA (2015) The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy. Cancer Immunol Res 3(3):219\u2013227. https:\/\/doi.org\/10.1158\/2326-6066.CIR-15-0009","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"7006_CR43","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10059-011-1057-8","volume":"32","author":"JY Park","year":"2011","unstructured":"Park JY, Lee SH, Yoon S, Park Y, Jung H, Kim T, Choi I (2011) IL-15-induced IL-10 increases the cytolytic activity of human natural killer cells. Mol Cells 32(3):265\u2013272. https:\/\/doi.org\/10.1007\/s10059-011-1057-8","journal-title":"Mol Cells"},{"issue":"31","key":"7006_CR44","doi-asserted-by":"publisher","first-page":"49008","DOI":"10.18632\/oncotarget.10264","volume":"7","author":"MD Scala","year":"2016","unstructured":"Scala MD, Gil-Fari\u00f1a I, Olag\u00fce C, Vales A, Sobrevals L, Fortes P, Corbacho D, Gonz\u00e1lez-Aseguinolaza G (2016) Identification of IFN-\u03b3-producing T cells as the main mediators of the side effects associated to mouse interleukin-15 sustained exposure. Oncotarget 7(31):49008\u201349026. https:\/\/doi.org\/10.18632\/oncotarget.10264","journal-title":"Oncotarget"},{"issue":"5466","key":"7006_CR45","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1126\/science.288.5466.675","volume":"288","author":"CC Ku","year":"2000","unstructured":"Ku CC, Murakami M, Sakamoto A, Kappler J, Marrack P (2000) Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 288(5466):675\u2013678. https:\/\/doi.org\/10.1126\/science.288.5466.675","journal-title":"Science"},{"issue":"6","key":"7006_CR46","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/s0016-5085(96)70036-7","volume":"111","author":"HC Reinecker","year":"1996","unstructured":"Reinecker HC, MacDermott RP, Mirau S, Dignass A, Podolsky DK (1996) Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology 111(6):1706\u20131713. https:\/\/doi.org\/10.1016\/s0016-5085(96)70036-7","journal-title":"Gastroenterology"},{"issue":"11","key":"7006_CR47","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1002\/eji.1830271121","volume":"27","author":"K Inagaki-Ohara","year":"1997","unstructured":"Inagaki-Ohara K, Nishimura H, Mitani A, Yoshikai Y (1997) Interleukin-15 preferentially promotes the growth of intestinal intraepithelial lymphocytes bearing gamma delta T cell receptor in mice. Eur J Immunol 27(11):2885\u20132891. https:\/\/doi.org\/10.1002\/eji.1830271121","journal-title":"Eur J Immunol"},{"issue":"2","key":"7006_CR48","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.4049\/jimmunol.0900420","volume":"183","author":"LJ Ma","year":"2009","unstructured":"Ma LJ, Acero LF, Zal T, Schluns KS (2009) Trans-presentation of IL-15 by intestinal epithelial cells drives development of CD8 alpha alpha IELs. J Immunol 183(2):1044\u20131054. https:\/\/doi.org\/10.4049\/jimmunol.0900420","journal-title":"J Immunol"},{"issue":"5","key":"7006_CR49","doi-asserted-by":"publisher","first-page":"e10842","DOI":"10.1371\/journal.pone.0010842","volume":"5","author":"R Bhadra","year":"2010","unstructured":"Bhadra R, Guan H, Khan IA (2010) Absence of both IL-7 and IL-15 severely impairs the development of CD8+ T cell response against Toxoplasma gondii. PLoS ONE 5(5):e10842. https:\/\/doi.org\/10.1371\/journal.pone.0010842","journal-title":"PLoS ONE"},{"issue":"7","key":"7006_CR50","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.4049\/jimmunol.147.7.2310","volume":"147","author":"FT Hakim","year":"1991","unstructured":"Hakim FT, Gazzinelli RT, Denkers E, Hieny S, Shearer GM, Sher A (1991) CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. J Immunol 147(7):2310\u20132316","journal-title":"J Immunol"},{"issue":"1","key":"7006_CR51","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4049\/jimmunol.149.1.175","volume":"149","author":"R Gazzinelli","year":"1992","unstructured":"Gazzinelli R, Xu Y, Hieny S, Cheever A, Sher A (1992) Simultaneous depletiong of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J Immunol 149(1):175\u2013180","journal-title":"J Immunol"},{"issue":"11","key":"7006_CR52","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1084\/jem.20011915","volume":"195","author":"IA Khan","year":"2002","unstructured":"Khan IA, Moretto M, Wei X, Williams M, Schwartzman JD, Liew FY (2002) Treatment with soluble interleukin-15R\u03b1 exacerbates intracellular parasitic infection by blocking the development of memory CD8+ T cell response. J Exp Med 195(11):1463\u20131470. https:\/\/doi.org\/10.1084\/jem.20011915","journal-title":"J Exp Med"},{"issue":"17","key":"7006_CR53","doi-asserted-by":"publisher","first-page":"6635","DOI":"10.1073\/pnas.0506180103","volume":"103","author":"CL Combe","year":"2006","unstructured":"Combe CL, Moretto MM, Schwartzman JD, Gigley JP, Bzik DJ, Khan IA (2006) Lack of IL-15 results in the suboptimal priming of CD4+ T cell response against an intracellular parasite. PNAS 103(17):6635\u20136640","journal-title":"PNAS"},{"issue":"11","key":"7006_CR54","doi-asserted-by":"publisher","first-page":"6729","DOI":"10.1128\/IAI.72.11.6729-6732.2004","volume":"72","author":"LA Lieberman","year":"2004","unstructured":"Lieberman LA, Villegas EN, Hunter CA (2004) Interleukin-15-deficient mice develop protective immunity to Toxoplasma gondii. Infect Immun 72(11):6729\u20136732. https:\/\/doi.org\/10.1128\/IAI.72.11.6729-6732.2004","journal-title":"Infect Immun"},{"issue":"3","key":"7006_CR55","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.micinf.2011.10.006","volume":"14","author":"P Perera","year":"2012","unstructured":"Perera P, Lichy JH, Waldmann TA, Perera LP (2012) The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use. Microbes Infect 14(3):247\u2013261. https:\/\/doi.org\/10.1016\/j.micinf.2011.10.006","journal-title":"Microbes Infect"},{"issue":"2","key":"7006_CR56","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1073\/pnas.1814642116","volume":"116","author":"RM Carrero","year":"2019","unstructured":"Carrero RM, Beceren-Braun F, Rivas SC, Hegde SM, Gangadharan A, Plote D, Pham G, Anthony SM, Schluns KS (2019) IL-15 is a component of inflammatory milieu in the tumor microenvironment promoting antitumor responses. PNAS 116(2):599\u2013608. https:\/\/doi.org\/10.1073\/pnas.1814642116","journal-title":"PNAS"},{"issue":"5Pt1","key":"7006_CR57","doi-asserted-by":"publisher","first-page":"G1201","DOI":"10.1152\/ajpgi.1997.272.5.G1201","volume":"272","author":"AC Stevens","year":"1997","unstructured":"Stevens AC, Matthews J, Andres P, Baffis V, Zheng XX, Chae DW, Smith J, Strom TB, Maslinski W (1997) Interleukin-15 signals T84 colonic epithelial cells in the absence of the interleukin-2 receptor beta-chain. Am J Physiol 272(5Pt1):G1201\u2013G1208. https:\/\/doi.org\/10.1152\/ajpgi.1997.272.5.G1201","journal-title":"Am J Physiol"},{"issue":"7","key":"7006_CR58","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.4049\/jimmunol.164.7.3608","volume":"164","author":"Z Liu","year":"2000","unstructured":"Liu Z, Geboes K, Colpaert S, D\u2019Haens GR, Rutgeerts P, Ceuppens JL (2000) IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J Immunol 164(7):3608\u20133615. https:\/\/doi.org\/10.4049\/jimmunol.164.7.3608","journal-title":"J Immunol"},{"issue":"10","key":"7006_CR59","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm1097-1124","volume":"3","author":"S Bulfone-Paus","year":"1997","unstructured":"Bulfone-Paus S, Ungureanu D, Pohl T, Lindner G, Paus R, R\u00fcckert R, Krause H, Kunzendorf U (1997) Interleukin-15 protects from lethal apoptosis in vivo. Nat Med 3(10):1124\u20131128. https:\/\/doi.org\/10.1038\/nm1097-1124","journal-title":"Nat Med"},{"issue":"1","key":"7006_CR60","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1006\/bbrc.1997.6435","volume":"233","author":"AL Angiolillo","year":"1997","unstructured":"Angiolillo AL, Kanegane H, Sgadari C, Reaman GH, Tosato G (1997) Interleukin-15 promotes angiogenesis in vivo. Biochem Biophys Res Commun 233(1):231\u2013237. https:\/\/doi.org\/10.1006\/bbrc.1997.6435","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"7006_CR61","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000048761","volume":"69","author":"H Kuniyasu","year":"2001","unstructured":"Kuniyasu H, Oue N, Nakae D, Tsutsumi M, Denda A, Tsujiuchi T, Yokozaki H, Yasui W (2001) Interleukin-15 expression is associated with malignant potential in colon cancer cells. Pathobiology 69(2):86\u201395. https:\/\/doi.org\/10.1159\/000048761","journal-title":"Pathobiology"},{"issue":"2","key":"7006_CR62","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<268::AID-IJC18>3.0.CO;2-4","volume":"82","author":"KB Reddy","year":"1999","unstructured":"Reddy KB, Krueger JS, Kondapaka SB, Diglio CA (1999) Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells. Int J Cancer 82(2):268\u2013273. https:\/\/doi.org\/10.1002\/(SICI)1097-0215(19990719)82:2<268::AID-IJC18>3.0.CO;2-4","journal-title":"Int J Cancer"},{"issue":"8","key":"7006_CR63","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1096\/fasebj.13.8.781","volume":"13","author":"J Westermarck","year":"1999","unstructured":"Westermarck J, K\u00e4h\u00e4ri VM (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13(8):781\u2013792","journal-title":"FASEB J"},{"issue":"3","key":"7006_CR64","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/sj.cdd.4400652","volume":"7","author":"D Finlay","year":"2000","unstructured":"Finlay D, Healy V, Furlong F, O\u2019Connell FC, Keon NK, Martin F (2000) MAP kinase pathway signalling is essential for extracellular matrix determined mammary epithelial cell survival. Cell Death Differ 7(3):302\u2013313. https:\/\/doi.org\/10.1038\/sj.cdd.4400652","journal-title":"Cell Death Differ"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-07006-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-07006-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-07006-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T17:29:09Z","timestamp":1674322149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-07006-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["7006"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-07006-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2022,1,4]]},"assertion":[{"value":"14 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}